These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26434609)

  • 21. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.
    Peel T; Cheng AC; Spelman T; Huysmans M; Spelman D
    Clin Microbiol Infect; 2012 Apr; 18(4):388-94. PubMed ID: 21848977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vancomycin-resistant enterococcus bacteraemia in an endemic region: clinical features and genomic analysis: a 12-year cohort.
    Abu-Lybdeh O; Murik O; Oster Y; Assous MV; Mann T; Zeevi DA; Benenson S; Wiener-Well Y
    J Hosp Infect; 2022 Mar; 121():105-113. PubMed ID: 34896188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
    Chou CH; Lee NY; Lee HC; Chang CM; Lee CC; Ko WC
    J Microbiol Immunol Infect; 2012 Jun; 45(3):221-7. PubMed ID: 22578639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.
    Kang Y; Vicente M; Parsad S; Brielmeier B; Pisano J; Landon E; Pettit NN
    Transpl Infect Dis; 2013 Oct; 15(5):466-73. PubMed ID: 23911080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unintended Consequences of Pretransplant Vancomycin-Resistant Enterococcus Screening on Antimicrobial Stewardship Among Allogeneic Hematopoietic Cell Transplant Recipients.
    Stohs EJ; MacAllister T; Pergam SA; Krantz EM; Jain R; Sweet A; Liu C
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):730-733. PubMed ID: 29589825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for development of vancomycin-resistant enterococcal bacteremia among VRE colonizers : A retrospective case control study.
    Kaya A; Kaya SY; Balkan II; Bayramlar OF; Mete B; Saltoglu N; Aygün G; Tabak ÖF
    Wien Klin Wochenschr; 2021 May; 133(9-10):478-483. PubMed ID: 32910333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes.
    Pelz RK; Lipsett PA; Swoboda SM; Diener-West M; Powe NR; Brower RG; Perl TM; Hammond JM; Hendrix CW
    Intensive Care Med; 2002 Jun; 28(6):692-7. PubMed ID: 12107672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vancomycin-Resistant Enterococcus Colonization and Bacteremia and Hematopoietic Stem Cell Transplantation Outcomes.
    Ford CD; Gazdik MA; Lopansri BK; Webb B; Mitchell B; Coombs J; Hoda D; Petersen FB
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):340-346. PubMed ID: 27890428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of morbidity and mortality after bloodstream infection with vancomycin-resistant versus -susceptible
    Bager P; Kähler J; Andersson M; Holzknecht BJ; Kjær Hansen SG; Schønning K; Nielsen KL; Koch K; Pinholt M; Voldstedlund M; Larsen AR; Kristensen B; Mølbak K; Sönksen UW; Skovgaard S; Skov R; Hammerum AM
    Emerg Microbes Infect; 2024 Dec; 13(1):2309969. PubMed ID: 38258968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies.
    Furtado GH; Mendes RE; Pignatari AC; Wey SB; Medeiros EA
    Am J Infect Control; 2006 Sep; 34(7):447-51. PubMed ID: 16945692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
    Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I
    Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of temporal clusters and risk factors of bacteremia by nosocomial vancomycin-resistant enterococci.
    da Silva NS; Muniz VD; Estofolete CF; Furtado GH; Rubio FG
    Am J Infect Control; 2014 Apr; 42(4):389-92. PubMed ID: 24679566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and Outcomes Associated With Infections Caused by Vancomycin-Resistant Enterococci in the United States: Systematic Literature Review and Meta-Analysis.
    Chiang HY; Perencevich EN; Nair R; Nelson RE; Samore M; Khader K; Chorazy ML; Herwaldt LA; Blevins A; Ward MA; Schweizer ML
    Infect Control Hosp Epidemiol; 2017 Feb; 38(2):203-215. PubMed ID: 27825401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal Multicenter Analysis of Outcomes After Cessation of Control Measures for Vancomycin-Resistant Enterococci.
    Lemieux C; Gardam M; Evans G; John M; Suh KN; vanWalraven C; Vicencio E; Coulby C; Roth V; Hota S
    Infect Control Hosp Epidemiol; 2017 Jan; 38(1):24-30. PubMed ID: 27804901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enterococcal bacteremia in febrile neutropenic children and adolescents with underlying malignancies, and clinical impact of vancomycin resistance.
    Bae KS; Shin JA; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    Infection; 2019 Jun; 47(3):417-424. PubMed ID: 30565009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
    Hefazi M; Damlaj M; Alkhateeb HB; Partain DK; Patel R; Razonable RR; Gastineau DA; Al-Kali A; Hashmi SK; Hogan WJ; Litzow MR; Patnaik MM
    Transpl Infect Dis; 2016 Dec; 18(6):913-920. PubMed ID: 27642723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
    Montecalvo MA; Jarvis WR; Uman J; Shay DK; Petrullo C; Horowitz HW; Wormser GP
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):437-42. PubMed ID: 11583213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center.
    Lodise TP; McKinnon PS; Tam VH; Rybak MJ
    Clin Infect Dis; 2002 Apr; 34(7):922-9. PubMed ID: 11880957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections.
    Chuang YC; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC
    Sci Rep; 2018 Jan; 8(1):1632. PubMed ID: 29374204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.